{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:00:26Z","timestamp":1762376426704,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defence Threat Reduction Agency","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.neuro.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T12:04:08Z","timestamp":1534593848000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Potentiation of antiseizure and neuroprotective efficacy of standard nerve agent treatment by addition of tariquidar"],"prefix":"10.1016","volume":"68","author":[{"given":"Gideon F.","family":"Meerhoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie M.","family":"Vester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hesseling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex S.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Lucassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marloes J.A.","family":"Joosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2018.08.005_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nyas.13028","article-title":"Long-term neuropathological and behavioral impairments after exposure to nerve agents","volume":"1374","author":"Aroniadou-Anderjaska","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuro.2018.08.005_bib0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12974-015-0421-6","article-title":"Altered morphological dynamics of activated microglia after induction of status epilepticus","volume":"12","author":"Avignone","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuro.2018.08.005_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2005.05.028","article-title":"Soman-induced convulsions: the neuropathology revisited","volume":"215","author":"Baille","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.neuro.2018.08.005_bib0020","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neuropharm.2008.02.008","article-title":"Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain","volume":"54","author":"Bankstahl","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2018.08.005_bib0025","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1124\/jpet.102.044644","article-title":"Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin","volume":"304","author":"Bueters","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuro.2018.08.005_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(97)01058-3","article-title":"Pharmacokinetics and effects of HI 6 in blood and brain of soman-intoxicated rats: a microdialysis study","volume":"332","author":"Cassel","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.tox.2004.11.036","article-title":"Soman poisoning increases neural progenitor proliferation and induces long-term glial activation in mouse brain","volume":"208","author":"Collombet","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.neuro.2018.08.005_bib0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neulet.2006.01.029","article-title":"Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus","volume":"398","author":"Collombet","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2018.08.005_bib0045","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1528-1167.2009.02478.x","article-title":"Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats","volume":"51","author":"de Araujo Furtado","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuro.2018.08.005_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neuro.2006.11.004","article-title":"Long-term behavioral consequences of soman poisoning in mice","volume":"28","author":"Filliat","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2018.08.005_bib0060","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/acs.molpharmaceut.6b00770","article-title":"P-gp protein expression and transport activity in rodent seizure models and human epilepsy","volume":"14","author":"Hartz","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuro.2018.08.005_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.toxlet.2011.05.231","article-title":"Increasing oxime efficacy by blood-brain barrier modulation","volume":"206","author":"Joosen","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuro.2018.08.005_bib0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cbi.2016.06.012","article-title":"Increasing nerve agent treatment efficacy by P-glycoprotein inhibition","volume":"259","author":"Joosen","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuro.2018.08.005_bib0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0773.1992.tb00558.x","article-title":"Pharmacokinetics of the oxime HI-6 from a mixture with atropine sulphate in dogs","volume":"71","author":"Jovanovic","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0080","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.410380609","article-title":"Experimental status epilepticus alters gamma-aminobutyric acid type A receptor function in CA1 pyramidal neurons","volume":"38","author":"Kapur","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pbb.2011.09.011","article-title":"Characterizing the behavioral effects of nerve agent-induced seizure activity in rats: increased startle reactivity and perseverative behavior","volume":"100","author":"Langston","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2018.08.005_bib0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/bdd.2510110305","article-title":"Intramuscular administration of atropine in the rat: jet spray versus conventional needle injection","volume":"11","author":"Lieske","year":"1990","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.neuro.2018.08.005_bib0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-008X(91)90329-D","article-title":"The synergism of atropine and the cholinesterase reactivator HI-6 in counteracting lethality by organophosphate intoxication in the rat","volume":"107","author":"Ligtenstein","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0100","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","article-title":"Several major antiepileptic drugs are substrates for human P-glycoprotein","volume":"55","author":"Luna-Tortos","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2018.08.005_bib0105","series-title":"Anonymous Chemical Warfare Agents: Toxicology and Treatment","first-page":"1","article-title":"Chemical warfare agents: toxicology and treatment, second edition","author":"Marrs","year":"2007"},{"key":"10.1016\/j.neuro.2018.08.005_bib0110","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuro.2018.08.005_bib0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pbb.2010.11.022","article-title":"Impaired auditory and contextual fear conditioning in soman-exposed rats","volume":"98","author":"Moffett","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2018.08.005_bib0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuro.2004.07.011","article-title":"Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: neuropathology and cognitive performance","volume":"26","author":"Myhrer","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2018.08.005_bib0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0091-3057(92)90019-C","article-title":"Behavioral performance, brain histology, and EEG sequela after immediate combined atropine\/diazepam treatment of soman-intoxicated rats","volume":"42","author":"Philippens","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2018.08.005_bib0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0361-9230(91)90097-4","article-title":"Cholinergic actions of diazepam and atropine sulfate in soman poisoning","volume":"26","author":"Shih","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuro.2018.08.005_bib0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.0.CO;2-D","article-title":"Neurochemical mechanisms in soman-induced seizures","volume":"17","author":"Shih","year":"1997","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/jpet.106.111252","article-title":"Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine","volume":"320","author":"Shih","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuro.2018.08.005_bib0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/15376516.2010.529190","article-title":"The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs","volume":"21","author":"Shih","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.neuro.2018.08.005_bib0160","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awh437","article-title":"Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures","volume":"128","author":"Volk","year":"2005","journal-title":"Brain"},{"issue":"Suppl. 9","key":"10.1016\/j.neuro.2018.08.005_bib0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1528-1167.2008.01928.x","article-title":"Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs","volume":"49","author":"Wasterlain","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuro.2018.08.005_bib0170","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuro.2018.08.005_bib0175","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/(SICI)1096-9861(19970224)378:4<482::AID-CNE4>3.0.CO;2-Z","article-title":"Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions","volume":"378","author":"Zimmer","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuro.2018.08.005_bib0180","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1523\/JNEUROSCI.18-10-03897.1998","article-title":"Nerve gas-induced seizures: role of acetylcholine in the rapid induction of Fos and glial fibrillary acidic protein in piriform cortex","volume":"18","author":"Zimmer","year":"1998","journal-title":"J. Neurosci."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X18301943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X18301943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:19:05Z","timestamp":1758982745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X18301943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":36,"alternative-id":["S0161813X18301943"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2018.08.005","relation":{},"ISSN":["0161-813X"],"issn-type":[{"type":"print","value":"0161-813X"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentiation of antiseizure and neuroprotective efficacy of standard nerve agent treatment by addition of tariquidar","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}